Ligand validation:2GYV

P3G: 3,6,9,12,15-PENTAOXAHEPTADECANE

P3G is a Ligand Of Interest in 2GYV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2GYV_P3G_B_546	18%	87%	0.158	0.852	0.55	0.15	-	-	1	0	41%	0.4118
4B84_P3G_A_1542	61%	45%	0.096	0.967	0.6	1.5	-	-	0	0	53%	0.5294
7V4O_P3G_A_201	38%	58%	0.147	0.85	0.65	0.96	-	1	2	0	100%	1
6FJ1_P3G_C_502	31%	30%	0.222	0.892	1.09	1.67	-	2	0	0	100%	1
4GUK_P3G_C_202	25%	40%	0.121	0.827	0.51	1.8	-	4	2	0	59%	0.5882
5OHI_P3G_A_917	23%	90%	0.197	0.82	0.2	0.41	-	-	0	0	100%	0.55
7RXX_P3G_A_403	2%	77%	0.258	0.497	0.58	0.35	-	-	1	0	100%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.